Literature DB >> 8590772

Successful intravenous immunoglobulin therapy for severe and persistent astrovirus gastroenteritis after fludarabine treatment in a patient with Waldenström's macroglobulinemia.

M Björkholm1, F Celsing, G Runarsson, J Waldenström.   

Abstract

A 78-year-old male with Waldenström's macroglobulinemia was after 23 years of conservative treatment given fludarabine phosphate in 1993 because of disease progression. Three weeks after the third fludarabine course he presented with a 5-day-history of watery diarrhoea, nausea and vomiting. Stool cultures were negative but a semiquantitative electron microscopy method demonstrated massive amounts of astrovirus (> 10(14) particles/ml). Symptomatic treatment was given but since his condition deteriorated, high-dose intravenous immunoglobulin (IvIg) treatment, 0.4 g/kg for four days was initiated. Within twenty-four hours all symptoms disappeared and the patient was discharged after a few days. A stool sample collected after two weeks demonstrated 10(7) particles/ml and after four weeks no astrovirus could be detected. The association between fludarabine and this opportunistic infection and the potential role of high dose IvIg treatment are discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8590772     DOI: 10.1016/0925-5710(95)00396-a

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  12 in total

Review 1.  Human astroviruses.

Authors:  Albert Bosch; Rosa M Pintó; Susana Guix
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

2.  Structure of a Human Astrovirus Capsid-Antibody Complex and Mechanistic Insights into Virus Neutralization.

Authors:  Walter A Bogdanoff; Jocelyn Campos; Edmundo I Perez; Lu Yin; David L Alexander; Rebecca M DuBois
Journal:  J Virol       Date:  2017-01-03       Impact factor: 5.103

3.  Astrovirus induces diarrhea in the absence of inflammation and cell death.

Authors:  Matthew D Koci; Lindsey A Moser; Laura A Kelley; Diane Larsen; Corrie C Brown; Stacey Schultz-Cherry
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

4.  Astrovirus-induced synthesis of nitric oxide contributes to virus control during infection.

Authors:  Matthew D Koci; Laura A Kelley; Diane Larsen; Stacey Schultz-Cherry
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

5.  Structural Basis for Escape of Human Astrovirus from Antibody Neutralization: Broad Implications for Rational Vaccine Design.

Authors:  Walter A Bogdanoff; Edmundo I Perez; Tomás López; Carlos F Arias; Rebecca M DuBois
Journal:  J Virol       Date:  2017-12-14       Impact factor: 5.103

6.  Diagnosis of neuroinvasive astrovirus infection in an immunocompromised adult with encephalitis by unbiased next-generation sequencing.

Authors:  Samia N Naccache; Karl S Peggs; Frank M Mattes; Rahul Phadke; Jeremy A Garson; Paul Grant; Erik Samayoa; Scot Federman; Steve Miller; Michael P Lunn; Vanya Gant; Charles Y Chiu
Journal:  Clin Infect Dis       Date:  2015-01-07       Impact factor: 9.079

Review 7.  Epidemiology of Classic and Novel Human Astrovirus: Gastroenteritis and Beyond.

Authors:  Diem-Lan Vu; Albert Bosch; Rosa M Pintó; Susana Guix
Journal:  Viruses       Date:  2017-02-18       Impact factor: 5.048

Review 8.  The Astrovirus Capsid: A Review.

Authors:  Carlos F Arias; Rebecca M DuBois
Journal:  Viruses       Date:  2017-01-19       Impact factor: 5.048

9.  Human Astrovirus 1-8 Seroprevalence Evaluation in a United States Adult Population.

Authors:  Lena Meyer; Kevin Delgado-Cunningham; Nicholas Lorig-Roach; Jordan Ford; Rebecca M DuBois
Journal:  Viruses       Date:  2021-05-25       Impact factor: 5.048

10.  De Novo Sequencing and Resurrection of a Human Astrovirus-Neutralizing Antibody.

Authors:  Walter A Bogdanoff; David Morgenstern; Marshall Bern; Beatrix M Ueberheide; Alicia Sanchez-Fauquier; Rebecca M DuBois
Journal:  ACS Infect Dis       Date:  2016-03-14       Impact factor: 5.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.